Cytomegalovirus Diagnostics Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Date : Apr 2018

Formats :
Report Code : PMR83649613

Category : Medical Devices
No Of Pages :
Global Cytomegalovirus Diagnostics Market

Cytomegalovirus CMV infection is the common herpes virus infection having different symptoms which occurs in all ages of people around the world. Cytomegalovirus CMV infection is a communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and semen. The infection may spread fast from urine or saliva from people who are infected with CMV having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery. Organ transplant and blood transfusion are the other way for the transmission for the disease.

Cytomegalovirus diagnostics market is mainly propelling by the rise in the prevalence of CMV infections, growing awareness about herpes disease, initiatives taken by key market players for the diagnosis of CMV infection are propelling the growth of CMV diagnostics market. Moreover, rise in the support of government, and development of healthcare infrastructure are anticipated to propel growth of CMV diagnostics market. Lack of awareness and price sensitivity are the few factors hampering the growth of CMV diagnostics market.

The global cytomegalovirus Diagnostics market is classified on the basis of test, application, enduser, and geography.
Based on test, the global cytomegalovirus Diagnostics market is segmented into the following:
Serology
Cell culture
Antigenemia assay
Polymerase Chain Reaction Amplification
Immunohistochemistry
Nucleic acid sequencebased amplification NASBA
Hybrid capture assay

Based on application, the global cytomegalovirus diagnostics market is segmented into the following
Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Others Mouth Ulcers, Pharyngitis, etc.

Based on the enduser, the global cytomegalovirus diagnostics market is segmented into the following:
Hospitals
Diagnostic Centers
Others

Rise in diagnosis of CMV cases propelling the growth of global cytomegalovirus diagnosis market. According to Public Health Agency of Canada, 40%100% of global population are having CMV antibody in the body. Patients with HIV and who has undergone organ transplantation, newborns, and premature infants are having high risk of CMV infection. As per Centres for Disease Control and Prevention 1 per 150 infants are born with CMV infection in U.S. but only 1 in 5 infants are infected with CMV are having long term health issues.

Geographically cytomegalovirus diagnostics market is segmented as Latin America, North America, Asia Pacific, Europe and The Middle East & Africa. Growing awareness about the herpes virus and rise in diagnosis of CMV cases in the developed regions such as Europe and North America are dominating the market. Initiatives taken by government about the awareness of the CMV disease, rise in healthcare expenditure and increase in disposable income are the few factors propelling market growth in AsiaPacific region.

In Jun 2018, Abbott received U.S. FDA approval for Realtime CMV molecular test, the only cytomegalovirus test which is available commercially which amplifies two selective regions of CMV genome

In May 2017, Roche received U.S. FDA approval for its cytomegalovirus CMV test used in recipients of hematopoietic stem cells transplantation
1. Executive Summary
2. Global Cytomegalovirus Diagnostics Market Introduction
2.1. Global Cytomegalovirus Diagnostics Market – Taxonomy
2.2. Global Cytomegalovirus Diagnostics Market –Definitions
2.2.1. Test Type
2.2.2. End User
3. Global Cytomegalovirus Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cytomegalovirus Diagnostics Market Dynamic Factors Impact Analysis
4. Global Cytomegalovirus Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
4.2. YearoverYear YoY Growth Analysis %
4.3. Market Opportunity Analysis
5. Global Cytomegalovirus Diagnostics Market, By Test Type, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1. Serology
5.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Cell Culture
5.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Antigenemia Assay
5.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. Polymerase Chain Reaction Amplification
5.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
5.5. Immunohistochemistry
5.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.5.3. Market Opportunity Analysis
5.6. Nucleic Acid Sequencebased Amplification NASBA
5.6.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.6.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.6.3. Market Opportunity Analysis
5.7. Hybrid Capture Assay
5.7.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
5.7.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
5.7.3. Market Opportunity Analysis
6. Global Cytomegalovirus Diagnostics Market, By Application, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1. Retinitis
6.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Pneumonia
6.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Gastroenteritis
6.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
6.4. Encephalitis
6.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.4.3. Market Opportunity Analysis
6.5. Others Mouth Ulcers, Pharyngitis, etc.
6.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
6.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
6.5.3. Market Opportunity Analysis
7. Global Cytomegalovirus Diagnostics Market, By End User, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1. Hospitals
7.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Diagnostic Centers
7.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
7.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
8. Global Cytomegalovirus Diagnostics Market Forecast, By Region, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1. North America
8.1.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.1.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.2.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. AsiaPacific
8.3.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.3.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.4.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
8.5.2. YearoverYear YoY Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Region, 2018 – 2024
9. North America Cytomegalovirus Diagnostics Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
9.1. Test Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.1.1. Serology
9.1.2. Cell culture
9.1.3. Antigenemia assay
9.1.4. Polymerase Chain Reaction Amplification
9.1.5. Immunohistochemistry
9.1.6. Nucleic acid sequencebased amplification NASBA
9.1.7. Hybrid capture assay
9.2. Application Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.2.1. Retinitis
9.2.2. Pneumonia
9.2.3. Gastrointestinal Ulcers
9.2.4. Encephalitis
9.2.5. Others Mouth Ulcers, Pharyngitis, etc.
9.3. End User Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Others
9.4. Country Analysis 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
9.4.1. U.S.
9.4.2. Canada
9.5. North America Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
9.6. North America Cytomegalovirus Diagnostics Market Dynamics – Trends
10. Europe Cytomegalovirus Diagnostics Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
10.1. Test Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.1.1. Serology
10.1.2. Cell culture
10.1.3. Antigenemia assay
10.1.4. Polymerase Chain Reaction Amplification
10.1.5. Immunohistochemistry
10.1.6. Nucleic acid sequencebased amplification NASBA
10.1.7. Hybrid capture assay
10.2. Application Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.2.1. Retinitis
10.2.2. Pneumonia
10.2.3. Gastrointestinal Ulcers
10.2.4. Encephalitis
10.2.5. Others Mouth Ulcers, Pharyngitis, etc.
10.3. End User Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
10.3.1. Hospitals
10.3.2. Diagnostic Centers
10.3.3. Others
10.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
10.6. Europe Cytomegalovirus Diagnostics Market Dynamics – Trends
11. AsiaPacific Cytomegalovirus Diagnostics Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
11.1. Test Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.1.1. Serology
11.1.2. Cell culture
11.1.3. Antigenemia assay
11.1.4. Polymerase Chain Reaction Amplification
11.1.5. Immunohistochemistry
11.1.6. Nucleic acid sequencebased amplification NASBA
11.1.7. Hybrid capture assay
11.2. Application Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.2.1. Retinitis
11.2.2. Pneumonia
11.2.3. Gastrointestinal Ulcers
11.2.4. Encephalitis
11.2.5. Others Mouth Ulcers, Pharyngitis, etc.
11.3. End User Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
11.3.1. Hospitals
11.3.2. Diagnostic Centers
11.3.3. Others
11.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of AsiaPacific
11.5. AsiaPacific Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
11.6. AsiaPacific Cytomegalovirus Diagnostics Market Dynamics – Trends
12. Latin America Cytomegalovirus Diagnostics Market Analysis, 2013 2013 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
12.1. Test Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.1.1. Serology
12.1.2. Cell culture
12.1.3. Antigenemia assay
12.1.4. Polymerase Chain Reaction Amplification
12.1.5. Immunohistochemistry
12.1.6. Nucleic acid sequencebased amplification NASBA
12.1.7. Hybrid capture assay
12.2. Application Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.2.1. Retinitis
12.2.2. Pneumonia
12.2.3. Gastrointestinal Ulcers
12.2.4. Encephalitis
12.2.5. Others Mouth Ulcers, Pharyngitis, etc.
12.3. End User Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
12.3.1. Hospitals
12.3.2. Diagnostic Centers
12.3.3. Others
12.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
12.6. Latin America Cytomegalovirus Diagnostics Market Dynamics – Trends
13. Middle East and Africa Cytomegalovirus Diagnostics Market Analysis, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn
13.1. Test Type Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.1.1. Serology
13.1.2. Cell culture
13.1.3. Antigenemia assay
13.1.4. Polymerase Chain Reaction Amplification
13.1.5. Immunohistochemistry
13.1.6. Nucleic acid sequencebased amplification NASBA
13.1.7. Hybrid capture assay
13.2. Application Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.2.1. Retinitis
13.2.2. Pneumonia
13.2.3. Gastrointestinal Ulcers
13.2.4. Encephalitis
13.2.5. Others Mouth Ulcers, Pharyngitis, etc.
13.3. End User Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn, YoY Growth %, and Market Share %
13.3.1. Hospitals
13.3.2. Diagnostic Centers
13.3.3. Others
13.4. Country Analysis 2013 2017 and Forecast 2018 – 2024 by Revenue USD Mn YoY Growth % and Market Share %
13.4.1. Gulf Cooperation Council GCC Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Cytomegalovirus Diagnostics Market Opportunity Analysis Index, By Test Type, By Application, By End User, and Country, 2018 – 2024
13.6. MEA Cytomegalovirus Diagnostics Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Cell Medical Ltd. U.K.
14.2.2. Merck & Co. Inc. U.S.
14.2.3. Chimerix, Inc. U.S.
14.2.4. Abbott Laboratories U.S.
14.2.5. Affymetrix, Inc. U.S.
14.2.6. Becton, Dickinson and Company U.S.
14.2.7. BioRad Laboratories, Inc. U.S.
14.2.8. F. HoffmannLa Roche Ltd. Switzerland
14.2.9. Johnson and Johnson Services Inc.,U.S.
15. Research Methodology
16. Key Assumptions and Acronyms
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....